Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)
News | Pharmaceuticals
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

Home July 10, 2024
Home
Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.
News | AHA
American Heart Association Announces New 2024-2025 National Volunteer Leaders

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

Home July 09, 2024
Home
Counties tend to be more rural and socioeconomically disadvantaged
News | Cardiovascular Business
Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY Endovascular Robotic Surgical System
News | Cardiovascular Clinical Studies
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
Vivek Reddy, MD
News | Atrial Fibrillation
Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

Home July 08, 2024
Home
Optum webinar pic
News | Structural Heart
Webinar on Optimizing Structural Heart Workflows to Take Place Next Week

On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows ...

Home July 08, 2024
Home
During the American Heart Association Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024 taking place in Chicago this week, two new, basic research studies in rodents (mice and rats) analyzed the impacts that alcohol may have on the heart.
News | AHA
New Research on Alcohol’s Impact on the Heart at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024

July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...

Home July 05, 2024
Home
Happy 4th from the DAIC team in Chicago
Feature | Cardiovascular Business
Happy 4th from the DAIC team

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
Researchers call for monitoring of quality, outcomes in era of private equity ownership
News | Cardiovascular Business
Study: Private Equity Acquisitions in Cardiology on the Rise

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions
News | Structural Heart
Cedars-Sinai Cardiologist Leads the American Society of Transplantation

July 3, 2024 —Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the Smidt ...

Home July 03, 2024
Home
Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels
News | Stents Drug Eluting
Biotronik Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES

July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro ...

Home July 02, 2024
Home
Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels
News | FDA
FDA Issues Left Ventricular Assist System Monitor Correction: Abbott Issues Correction for HeartMate LVAS System Monitor due to Screen Issues that May Cause Unintentional Pump Stop

July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...

Home July 02, 2024
Home
List of DAIC's Top 10 articles for June
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
DAIC's Top 10 for June

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer
News | Cardiovascular Business
CVRx Announces Key Senior Leadership Team Hires

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
The program aims to improve health outcomes, with a focus on increasing awareness of the symptoms and risks of hypertension
News | Hypertension
Expansion of AstraZeneca’s Flagship Health Equity Program Healthy Heart Africa

June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...

Home June 28, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now